You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Paromomycin sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for paromomycin sulfate and what is the scope of patent protection?

Paromomycin sulfate is the generic ingredient in two branded drugs marketed by King Pfizer, Parkedale, Heritage, Sun Pharm Inds Inc, and Parke Davis, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for paromomycin sulfate. One supplier is listed for this compound.

Summary for paromomycin sulfate
US Patents:0
Tradenames:2
Applicants:5
NDAs:5
Drug Master File Entries: 1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 65
Clinical Trials: 9
Patent Applications: 3,572
What excipients (inactive ingredients) are in paromomycin sulfate?paromomycin sulfate excipients list
DailyMed Link:paromomycin sulfate at DailyMed
Recent Clinical Trials for paromomycin sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Institute of Endemic Diseases (IEND), University of KhartoumPhase 3
University of GondarPhase 3
Makerere UniversityPhase 3

See all paromomycin sulfate clinical trials

Pharmacology for paromomycin sulfate
Drug ClassAntiprotozoal
Medical Subject Heading (MeSH) Categories for paromomycin sulfate

US Patents and Regulatory Information for paromomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parkedale HUMATIN paromomycin sulfate CAPSULE;ORAL 060521-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage PAROMOMYCIN SULFATE paromomycin sulfate CAPSULE;ORAL 065173-001 Dec 14, 2007 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
King Pfizer HUMATIN paromomycin sulfate CAPSULE;ORAL 062310-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parke Davis HUMATIN paromomycin sulfate SYRUP;ORAL 060522-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.